Skip to main content Back to Top


Magnesium Citrate Oral Solution

Products Affected - Description

    • Magnesium citrate oral solution, Vi-Jon, 1.745 gm/30 mL, 10 ounce bottle, Product : all brands

Reason for the Shortage

    • On June 21, 2022, Vi-Jon recalled one lot of CVS magnesium citrate lemon flavored oral solution due to contamination with Gluconacetobacter liquefaciens. On July 25, 2022, the recall was expanded to include all flavors and lots of magnesium citrate oral solution. Additional information including the complete list of affected products can be found at
    • Vi-Jon is a key supplier of magnesium citrate oral solution.

Available Products

    • There are no presentations available

Estimated Resupply Dates

    • Magnesium citrate saline laxative oral solution 10 ounce bottles are unavailable and the distributing companies cannot estimate when additional product will be available.

Alternative Agents & Management

    • Oral magnesium citrate is commonly used as a component of bowel preparations prior to colonoscopy and as a laxative. Guidelines from the American Society for Gastrointestinal Endoscopy (ASGE) do not recommend oral magnesium citrate as part of a bowel preparation due to limited efficacy and potential toxicity. Oral magnesium citrate is also used as a laxative. ASGE Guidelines can be found at
    • If additional bowel preparation is required beyond the usual polyethylene glycol (Miralax) and bisacodyl that are recommended for most patients, prescription oral sodium sulfate (Suprep) or oral sodium sulfate with PEG-ELS (Suclear) may be useful. Use alternative laxatives such as milk of magnesia or lactulose if oral magnesium is being used only as a laxative vs. bowel preparation. Milk of magnesia is not a good alternative for use as a bowel preparation because it is opaque and not clear.


Updated July 13, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. Created August 4, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.



Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.